EPO and hepatocellular carcinoma: Previous clinical reports have recorded erythrocytosis and an increase in EPO serum levels in patients with hepatocellular carcinoma (Cheng et al. 2002), whereas histological evidences of augmented EPO synthesis have been identified from the analysis of hepatic cancer samples and liver tissue surrounding the tumor (Ribatti et al. 2007).